Search research articles
Contact Us
Filters
Showing results (1-10 of 116) with videos related to
Page
of 12
Sort By:
Statistics in Medicine
|
September 17, 2020
A simulation-free approach to assessing the performance of the continual reassessment method
Thomas M Braun
Statistics in Medicine
|
October 12, 2005
Generalizing the TITE-CRM to adapt for early- and late-onset toxicities
Thomas M Braun
Biometrics
|
March 14, 2018
Motivating sample sizes in adaptive Phase I trials via Bayesian posterior credible intervals
Thomas M Braun
Biometrical Journal. Biometrische Zeitschrift
|
July 12, 2007
A mixed model-based variance estimator for marginal model analyses of cluster randomized trials
Thomas M Braun
Chinese Clinical Oncology
|
April 6, 2015
The current design of oncology phase I clinical trials: progressing from algorithms to statistical models
Thomas M Braun
Controlled Clinical Trials
|
June 12, 2002
The bivariate continual reassessment method. extending the CRM to phase I trials of two competing outcomes
Thomas M Braun
Statistics in Medicine
|
June 6, 2022
Extending the Continual Reassessment Method to accommodate step-up dosing in Phase I trials
Thomas M Braun, Francois Mercier
Statistics in Biopharmaceutical Research
|
January 18, 2014
A Generalized Continual Reassessment Method for Two-Agent Phase I Trials
Thomas M Braun, Nan Jia
Journal of the American Statistical Association
|
November 14, 2013
A Phase I Bayesian Adaptive Design to Simultaneously Optimize Dose and Schedule Assignments Both Between and Within Patients
Jin Zhang, Thomas M Braun
Statistics in Medicine
|
July 15, 2015
Tests for time-invariant correlation of longitudinally measured biomarkers
Su Chen, Thomas M Braun
Page
of 12
Search research articles
Search
Showing results (1-10 of 116) with videos related to
Sort By:
Page
of 12
Statistics in Medicine
|
September 17, 2020
A simulation-free approach to assessing the performance of the continual reassessment method
Thomas M Braun
Statistics in Medicine
|
October 12, 2005
Generalizing the TITE-CRM to adapt for early- and late-onset toxicities
Thomas M Braun
Biometrics
|
March 14, 2018
Motivating sample sizes in adaptive Phase I trials via Bayesian posterior credible intervals
Thomas M Braun
Biometrical Journal. Biometrische Zeitschrift
|
July 12, 2007
A mixed model-based variance estimator for marginal model analyses of cluster randomized trials
Thomas M Braun
Chinese Clinical Oncology
|
April 6, 2015
The current design of oncology phase I clinical trials: progressing from algorithms to statistical models
Thomas M Braun
Controlled Clinical Trials
|
June 12, 2002
The bivariate continual reassessment method. extending the CRM to phase I trials of two competing outcomes
Thomas M Braun
Statistics in Medicine
|
June 6, 2022
Extending the Continual Reassessment Method to accommodate step-up dosing in Phase I trials
Thomas M Braun, Francois Mercier
Statistics in Biopharmaceutical Research
|
January 18, 2014
A Generalized Continual Reassessment Method for Two-Agent Phase I Trials
Thomas M Braun, Nan Jia
Journal of the American Statistical Association
|
November 14, 2013
A Phase I Bayesian Adaptive Design to Simultaneously Optimize Dose and Schedule Assignments Both Between and Within Patients
Jin Zhang, Thomas M Braun
Statistics in Medicine
|
July 15, 2015
Tests for time-invariant correlation of longitudinally measured biomarkers
Su Chen, Thomas M Braun
Page
of 12